Compare AGI & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGI | ZBH |
|---|---|---|
| Founded | 2003 | 1927 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Industrial Specialties |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 16.0B |
| IPO Year | 2002 | 2001 |
| Metric | AGI | ZBH |
|---|---|---|
| Price | $38.93 | $87.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 21 |
| Target Price | $51.50 | ★ $101.00 |
| AVG Volume (30 Days) | ★ 2.6M | 2.0M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | 0.28% | ★ 1.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.22 |
| Revenue | N/A | ★ $8,231,500,000.00 |
| Revenue This Year | $59.50 | $4.96 |
| Revenue Next Year | $14.28 | $3.76 |
| P/E Ratio | ★ $34.21 | $69.66 |
| Revenue Growth | N/A | ★ 7.20 |
| 52 Week Low | $23.92 | $79.12 |
| 52 Week High | $55.41 | $108.29 |
| Indicator | AGI | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 42.97 | 57.64 |
| Support Level | $37.55 | $85.38 |
| Resistance Level | $40.21 | $102.52 |
| Average True Range (ATR) | 1.52 | 2.12 |
| MACD | -0.00 | 0.53 |
| Stochastic Oscillator | 34.35 | 84.99 |
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has three operating segments being Young-Davidson, Island Gold District's operation operates in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Island Gold District mines.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.